相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Evaluation of Dual Immunohistochemistry and Chromogenic In Situ Hybridization for HER2 on a Single Section
Emily S. Reisenbichler et al.
AMERICAN JOURNAL OF CLINICAL PATHOLOGY (2012)
Genetic heterogeneity in HER2 testing may influence therapy eligibility
Barbara Bernasconi et al.
BREAST CANCER RESEARCH AND TREATMENT (2012)
- POINT - Fluorescence In Situ Hybridization Is the Preferred Approach over Immunohistochemistry for Determining HER2 Status
Jeffrey S. Ross
CLINICAL CHEMISTRY (2011)
High False- Negative Rate of HER2 Quantitative Reverse Transcription Polymerase Chain Reaction of the Oncotype DX Test: An Independent Quality Assurance Study
David J. Dabbs et al.
JOURNAL OF CLINICAL ONCOLOGY (2011)
Fluorescent In Situ Hybridization for Human Epidermal Growth Factor Receptor 2 Assessment in Breast Cancer: Is It Applicable As a Primary Test?
Vincenzo Arena et al.
JOURNAL OF CLINICAL ONCOLOGY (2009)
HER-2 Gene Amplification, HER-2 and Epidermal Growth Factor Receptor mRNA and Protein Expression, and Lapatinib Efficacy in Women with Metastatic Breast Cancer
Michael F. Press et al.
CLINICAL CANCER RESEARCH (2008)
Development of automated brightfield double In Situ hybridization (BDISH) application for HER2 gene and chromosome 17 centromere (CEN 17) for breast carcinomas and an assay performance comparison to manual dual color HER2 fluorescence In Situ hybridization (FISH)
Hiroaki Nitta et al.
DIAGNOSTIC PATHOLOGY (2008)
HER2 status and benefit from adjuvant trastuzumab in breast cancer
Soonmyung Paik et al.
NEW ENGLAND JOURNAL OF MEDICINE (2008)
PGDS, a novel technique combining chromogenic in situ hybridization and immunohistochemistry for the assessment of ErbB2 (HER2/neu) status in breast cancer
Ruoyu Ni et al.
APPLIED IMMUNOHISTOCHEMISTRY & MOLECULAR MORPHOLOGY (2007)
HER2 testing in the UK: consensus from a national consultation
M. Dowsett et al.
JOURNAL OF CLINICAL PATHOLOGY (2007)
Analytical validation and interobserver reproducibility of EnzMet GenePro - A second-generation bright-field metallography assay for concomitant detection of HER2 gene status and protein expression in invasive carcinoma of the breast
E Downs-Kelly et al.
AMERICAN JOURNAL OF SURGICAL PATHOLOGY (2005)
Chromogenic in situ hybridization (CISH): a novel alternative in screening archival breast cancer tissue samples for HER-2/neu status
MA Madrid et al.
BREAST CANCER RESEARCH (2004)
分享论文
